Evidence map›Paper›PMID 36013197›Full record

ArticleJournal of personalized medicine2022

The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary Breast and Ovarian Cancer.

Carla Pedrazzani, Monica Aceti, Reka Schweighoffer, Andrea Kaiser-Grolimund, Nicole Bürki, Pierre O Chappuis, Rossella Graffeo, Christian Monnerat, Olivia Pagani, Manuela Rabaglio and 2 more

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carla PedrazzaniDepartment of Clinical Research, Faculty of Medicine, University of Basel, 4055 Basel, Switzerland.
Monica AcetiDepartment of Clinical Research, Faculty of Medicine, University of Basel, 4055 Basel, Switzerland.ORCID 0000-0002-9614-4038
Reka SchweighofferDepartment of Clinical Research, Faculty of Medicine, University of Basel, 4055 Basel, Switzerland.
Andrea Kaiser-GrolimundSwiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland.ORCID 0000-0001-9416-3473
Nicole BürkiWomen's Clinic, University Hospital Basel, 4031 Basel, Switzerland.
Pierre O ChappuisOncogenetics Unit, Service of Oncology, University Hospital of Geneva, 1205 Geneva, Switzerland.ORCID 0000-0002-3464-9241
Rossella GraffeoOncology Institute of Southern Switzerland, 6900 Lugano, Switzerland.
Christian MonneratDepartment of Medical Oncology, Jura Hospital, 2800 Delémont, Switzerland.
Olivia PaganiOncology Institute of Southern Switzerland, 6900 Lugano, Switzerland.
Manuela RabaglioDepartment of Medical Oncology, Inselspital University Hospital, 3010 Bern, Switzerland.ORCID 0000-0002-6764-1844
Maria C KatapodiDepartment of Clinical Research, Faculty of Medicine, University of Basel, 4055 Basel, Switzerland.ORCID 0000-0003-3903-3750
Maria Caiata-ZuffereyDepartment of Business Economics, Health and Social Care, University of Applied Science and Arts of Southern Switzerland, 6928 Manno, Switzerland.ORCID 0000-0003-4197-8913

Funding

Swiss Cancer League KLS-4294-08-2017Swiss Cancer Research Foundation KFS-5293-02-2021University of Basel Forschungsfonds 2017
6 · The paper itself

Abstract

Low uptake of genetic services among members of families with hereditary breast and ovarian cancer (HBOC) suggests limitations of proband-mediated communication of genetic risk. This study explored how genetic information proceeds from healthcare providers to probands and from probands to relatives, from the probands' perspectives. Using a grounded-theory approach, we analyzed narrative data collected with individual interviews and focus groups from a sample of 48 women identified as carriers of HBOC-associated pathogenic variants from three linguistic regions of Switzerland. The findings describe the "communication chain", confirming the difficulties of proband-mediated communication. Provider-proband communication is impacted by a three-level complexity in the way information about family communication is approached by providers, received by probands, and followed-up by the healthcare system. Probands' decisions regarding disclosure of genetic risk are governed by dynamic and often contradictory logics of action, interconnected with individual and family characteristics, eventually compelling probands to engage in an arbitrating process. The findings highlight the relevance of probands' involvement in the communication of genetic risk to relatives, suggesting the need to support them in navigating the complexity of family communication rather than replacing them in this process. Concrete actions at the clinical and health system levels are needed to improve proband-mediated communication.

Indexed as

cascade genetic screeningcounsellinggenetic riskgrounded theoryHBOCintra-familial communicationproband-mediated communicationtier 1 genetic condition

Identifiers

PMID36013197
PMCPMC9409642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.